Clinical Trials in Phoenix

Showing 10781-10800 of 16,646 trials

Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

NCT00958334

ZPU-003 EXT is a 2-year extension study of ZPU-003 (NCT00882258) to determine the continued safety and efficacy of Proellex in women who have previously completed the double-blind portion of the study.

Uterine Fibroids

Repros Therapeutics Inc.65 participantsStarted Sep 2006

Phoenix, Arizona, United States • Phoenix, Arizona, United States • San Diego, California, United States +8 more locations

COMPLETEDPhase 3< 1 mile

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

NCT02387359

This study in patients with IBS-C is a randomized, double-blind, placebo-controlled, parallel-group clinical trial with 12 weeks of study drug therapy.

Irritable Bowel Syndrome Characterized by Constipation

Bausch Health Americas, Inc.1,054 participantsStarted Dec 2014

Athens, Alabama, United States • Birmingham, Alabama, United States • Dothan, Alabama, United States +152 more locations

Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Find Trials by Condition in Phoenix

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

Food Effect Study of CTP-543 in Healthy Volunteers

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

Evaluating VR Therapy Using Cold Pressor Test

Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

Assessing Superion Clinical Endpoints vs. Decompression

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Indomethacin PK and PD Therapy in Pregnancy

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency